PeopleBio, Inc. (KOSDAQ:304840)

Market Cap	52.19B
Revenue (ttm)	3.77B
Net Income (ttm)	-10.62B
Shares Out	21.17M
EPS (ttm)	-488.40
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,727
Average Volume	80,208
Open	2,370.00
Previous Close	2,370.00
Day's Range	2,365.00 - 2,390.00
52-Week Range	2,325.00 - 6,090.00
Beta	0.56
RSI	43.39
Earnings Date	Aug 14, 2025

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2002
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 304840

Financial Performance

In 2024, PeopleBio's revenue was 3.73 billion, a decrease of -16.20% compared to the previous year's 4.45 billion. Losses were -10.91 billion, -31.94% less than in 2023.